drugset / Trial / NCT05939882
Low Concentration Atropine in the Prevention of Myopia in Children.
RandomizedParallel-groupDouble-blindPrevention
Summary
This double-blind, randomized controlled clinical study is to evaluate the effectiveness and safety of low concentration atropine in preventing myopia in pre-myopia children, and to explore whether there is a dose effect relationship between different concentrations of atropine in preventing myopia.
Timeline
- Start
- 2023-04-01
- Primary completion
- 2024-04
- Completion
- 2024-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atropine | Other / unclassified | 0.01 % | Topical |
| Subject | Atropine | Other / unclassified | 0.02 % | Topical |
| Subject | Atropine | Other / unclassified | 0.04 % | Topical |